Muscarinic receptor agonists and antagonists: Effects on cancer

Medicine & Life Sciences

• Muscarinic Agonists 86%
• Muscarinic Antagonists 80%
• Muscarinic Receptors 71%
• Neoplasms 21%
• Growth 20%
• Cholinergic Agents 15%
• Muscarinic M3 Receptors 12%
• Pancreatic Neoplasms 7%
• Brain Neoplasms 7%
• Acetylcholine 7%
• Ovarian Neoplasms 7%
• Colonic Neoplasms 7%
• Melanoma 6%
• Intercellular Signaling Peptides and Proteins 6%
• Prostatic Neoplasms 6%
• Lung Neoplasms 6%
• Endothelial Cells 6%
• Epithelial Cells 5%
• Clinical Trials 5%
• Breast Neoplasms 5%
• Pharmaceutical Preparations 3%
• Therapeutics 2%

Chemical Compounds

• Muscarinic Agonist 100%
• Agent Interacting With Transmitter, Hormone or Drug Receptor 72%
• Antagonist 60%
• Cholinergic 41%
• Parasympathomimetic Agent 20%
• Adjuvant 20%
• Growth Factor 19%
• Acetylcholine 17%
• Drug 8%